ASPs to drop even as glove demand stays up post-pandemic — AmInvestment Bank KUALA LUMPUR (Nov 12): AmInvestment Bank believes that while glove demand will stay stable post-Covid-19 pandemic, average selling prices (ASPs) will drop as there will no longer be a rush for gloves. We reckon that ASP will stabilise at a higher level than pre-pandemic level due to the broader usage of gloves,” it said in a note on Top Glove Corp Bhd today.
The research house’s analyst Thong Pak Leng said it believed that glove demand will remain strong, based on reasons outlined by Top Glove during a webinar, which include a higher awareness of personal hygiene and broader use of gloves beyond the healthcare sector. In addition, Thong said there may not be an oversupply of gloves after the pandemic, as Top Glove had pointed out that there are key issues in ramping up supply that need to be addressed, including the availability of contractors to build production lines, the shortage of foreign workers and constraint of nitrile raw material.
Top Glove has also allocated 30% of its capacity for spot orders. “The spot orders for nitrile glove have been fully sold for the next three months. Meanwhile, the spot orders for natural rubber powder-free gloves are also increasing due to the long lead time of nitrile gloves,” said Thong. Presently, Top Glove has a total production capacity of 90 billion pieces per annum.
To expand further, Top Glove has allocated capital expenditure of RM10 billion over the next five years for capacity expansion to double its current capacity by the end of 2025, said Thong. This will be done in stages whereby 14 billion pieces will be added for FY21 and 16 billion for FY22.
AmInvestment Bank maintains its "hold" call on the stock with a lower fair value of RM7.88, adding that the group’s fundamentals remain solid for the next few years.
“We maintain our view that Top Glove’s net profit will peak in FY21 as demand soars from the Covid-19 pandemic with increased capacity expansions. We make no changes to our FY21–FY23 net profit forecasts at RM6.5 billion, RM2.3 billion and RM2.2 billion respectively.
“Our ASP assumptions are US$60 per 1,000 pieces for FY21, US$35 per 1,000 pieces for FY22 and US$28 per 1,000 pieces for FY23 with an average utilisation rate of more than 80%,” said Thong.
Top Glove is currently fourth on Bursa’s top losers list, having fallen 19 sen or 2.42% to RM7.67. The stock is currently valued at RM62.34 billion.
Believe China Vaccine not working. See Brazil new cases have started to rise again 48,000 ++. Believe also there was a fatal case in one of the volunteers.
No joy for glove stocks... most penny and speculative stocks went up. Tomorrow it's oil and gas stocks. Get ready for the big bucks. Forget about glove stocks.
What you need to know More than 50 million cases of Covid-19 have been recorded worldwide. The US has surpassed 10.5 million cases and 240,000 deaths, with several states breaking daily case records. The Centers for Disease Control and Prevention projects there will be up to 282,000 US coronavirus deaths by December 5.
The US Food and Drug Administration might not complete its review of Pfizer’s Covid-19 vaccine until Christmas, according to the head of the federal network coordinating Covid-19 vaccine clinical trials.
The United States has so far reported over 150,000 new coronavirus cases, the highest daily figure anywhere in the world since the pandemic began. Worldwide coronavirus cases pass 52.5 million
Thise who can hold.. maybe just hold..wait until the ib/big boy collect enough..maybe we need to see the proce drop below rm3 before it will rebound..maybe its true they are controlling the price.. those who cant hold you may sell at any price u feel better..
We need to ensure seller become lesser/very min before he take off.. just chills guys.. target to rebound somewhere near 23rd nov n above..
Clearly the US market already knows that Pfizers Vaccine will not be a practical solution. The vaccines will be useless once exposed to room temp. Even if SATs say they the ultra freezing equipment, what about the trucks from manufacture to the aircraft, the aircraft cargo, ground transporters, hospitals in major cities, etc, etc.
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
strattegist
23,459 posts
Posted by strattegist > 2020-11-12 15:25 | Report Abuse
red